Remove 2030 Remove Diagnostic Remove Patient Care
article thumbnail

Growth in Demand for Imaging Procedures Will Increase Need for Teleradiology

Vesta Teleradiology

By the NuMbers Diagnostic imaging is becoming increasingly crucial in healthcare, with the market projected to reach $31.9bn in 2023 and grow at a 4.8% CAGR to $45.8bn in 2030. Challenges include high equipment costs and a shortage of skilled personnel, impacting accessibility and patient care quality.

article thumbnail

RSNA, SPR Partner for JPR Meetings in São Paulo, Brazil

Imaging Technology

milla1cf Tue, 05/07/2024 - 13:16 May 7, 2024 — The Radiological Society of North America (RSNA) and the Radiological and Diagnostic Imaging Society of São Paulo (SPR) have agreed to continue their partnership for the joint planning of Jornada Paulista de Radiologia (JPR) in 2026, 2028 and 2030.

Education 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lunit targets U.S. market, expanded AI portfolio with bid for Volpara

AuntMinnie

Lunit has been actively pursuing global expansion, including participation in Saudi Arabia’s Saudi Vision 2030 Healthcare Sandbox and forming a partnership to help develop Saudi Arabia’s national cancer screening program. Lunit’s CXR Triage software for triage of emergency x-ray cases garnered FDA clearance in November 2021.

X-ray 112
article thumbnail

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

Imaging Technology

Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. We have many endocrine options now, and FES PET may identify patients who remain ER+ and thus potentially benefit from endocrine based therapy.”

Clinic 94
article thumbnail

Lunit Announces Completion of Volpara Acquisition to Advance AI-driven Cancer Care

Imaging Technology

christine.book Wed, 05/22/2024 - 09:59 May 22, 2024 — Lunit , a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, today announced the successful completion of its acquisition of Volpara Health Technologies, Ltd., a global developer of medical software for breast cancer screening.

article thumbnail

Minnies winners for 2023 highlight AI, innovation in radiology

AuntMinnie

Our hope is that we'll be able to determine how to use this as a diagnostic tool in actual practice,” he said. He added that by the age of 50 or 60, many or most people have already had a CT scan for diagnostic purposes. “We We can first take advantage of all those scans,” he said. Maryland is a testing ground," he continued.

Radiology 132